Hendrik Scholl is one of the two founding directors of the Institute of Molecular and Clinical Ophthalmology Basel (IOB). He is also Professor and Chairman of the Department of Ophthalmology, University of Basel, Switzerland. He specializes in the treatment of retinal diseases, specifically inherited retinal and macular dystrophies, and in research on retinal neurodegeneration.
Prof. Scholl is a graduate of the Medical Faculty of the University of Tübingen/Germany and holds a Master of Arts from Tübingen’s Faculty of Philosophy. He completed a residency at Tübingen’s University Eye Hospital prior to a fellowship at Moorfields Eye Hospital & Institute of Ophthalmology in London/UK and a DFG Heisenberg fellowship on macular disorders. After having held several academic positions at the Medical Faculty of the University of Bonn/Germany from 2004, he was appointed as Professor of Ophthalmology in 2010 and as Endowed Chair in 2011 at the prestigious Wilmer Eye Institute of John Hopkins University Medical School in Baltimore/USA. At the Johns Hopkins Hospital, Prof. Scholl headed the Retinal Degeneration Clinic and the Visual Neurophysiology Service and was appointed as Co-director of the university’s Center for Stem Cells and Ocular Regenerative Medicine (STORM).
In 2016, Prof. Scholl joined the University of Basel as Professor and Chairman of the Department of Ophthalmology. Prof. Scholl has authored over 200 articles and reviews in peer-reviewed journals and received numerous prestigious awards, including the European Vision Award, the President’s Award of the American Society of Retinal Specialists, the W. Richard Green Award and the Paul Henkind Memorial Award of the Macula Society, and the Swiss Alfred-Vogt Award.
Prof. Scholl is married. He lives in the Basel area with his wife and two children.